Startup | January 27, 2022
Botanical Solution Inc. raises $6.1 million in Series A
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
Filing marks first protein-based vaccine submitted to MHRA for authorization
UFlex has committed close to US $ 10 million towards various initiatives at its overseas and Indian plants to repurpose plastic waste
First participants enrolled in Phase 1 clinical trial of combination NanoFlu/NVX-CoV2373 vaccine with Matrix-M adjuvant. The Phase 1/2 study will also evaluate immunogenicity and safety
Filing for WHO Emergency Use Authorisation this month
Deal for 100 million doses with additional 100 million through 2023
The first batch will be shipped to the Gamaleya Center for the quality control
Subscribe To Our Newsletter & Stay Updated
